MON-653 The Effects of DPP IV Inhibitor on Glycemic Variability in Type 2 Diabetic Patients Treated with Twice Daily Premixed Human Insulin

Glycemic variability (GV) is emerging as an exciting therapeutic target for diabetes mellitus (DM) with recent evidences showing association of GV with hypoglycemia risk as well as chronic complications.(1,2) Twice daily human premixed insulin is commonly used in developing countries and Asia for tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Florence Hui Sieng, Tong, Chin Voon, Kuan, Yueh Chien, Lau, Bik Kui, Loh, Huai Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Diabetes Mellitus and Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209463/
http://dx.doi.org/10.1210/jendso/bvaa046.783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209463/
http://dx.doi.org/10.1210/jendso/bvaa046.783

Ejemplares similares